Biotechnology R&D expenditures in Spain declined 3.3% in 2012 to €1,455 million ($1,865 million), following a 4.4% decline in 2011, to account for 11% of total Spanish R&D spending. Biotech R&D spending by government, business and higher education declined 3.7%, 2.7% 3.8% to make up 40%, 36% and 24% of total internal biotech R&D expenditures, respectively. By funding source, government, business, foreign sources, higher education and private nonprofit institutions (PNPI) accounted for 55%, 28%, 6%, 10% and 1%, respectively. On a full-time equivalent (FTE) basis, the number of persons dedicated to internal biotech R&D decline 0.7% in 2012 to 24,121, or 11% of all R&D employees, and the number of researchers fell 0.7% to 15,565. Government, higher education, business and PNPI accounted for 42%, 31% and 27% of FTE biotech R&D researchers. In the business sector, services, industry and agriculture represented 70%, 27% and 4% of biotech R&D spending. Cataluña, Comunidad de Madrid and Andalucia accounted for 30%, 27% and 11% of biotech R&D expenditures.

Source: Instituto Nacional de Estadística